Skip to main content

Table 1 Distribution of propensity score by treatment group in the BRAVO study

From: Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree

 

Treatment group

Placebo

Laquinimod 0.6 mg/day

Estimate

Estimate

Quartile

  

Maximum

Upper quartile

0.701

0.529

Median

0.586

0.407

Lower quartile

0.440

0.267

Minimum

0.109

0.007

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us